Sector Chart Egetis Therapeutics AB

Equities

EGTX

SE0003815604

Delayed Nasdaq Stockholm 03:30:10 2024-06-26 EDT 5-day change 1st Jan Change
5.69 SEK -2.90% Intraday chart for Egetis Therapeutics AB -27.20% +2.15%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
163M -
122B
116B
27.03B -
20.36B -
15.91B -